JAIME OWENS: Open Payments
NPI 1235656695 · JENKINTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$645 in 27 payments from 7 companies in 2025. Trend: 2023 $39 · 2024 $855 · 2025 $645
Food & beverage: $645
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $288 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $88 |
| Braeburn Inc. | 4 | $88 |
| Alkermes, Inc. | 2 | $66 |
| Indivior Inc. | 3 | $54 |
| Neuronetics, Inc. | 3 | $32 |
| Neurocrine BioSciences, Inc. | 1 | $30 |
Products named: VRAYLAR, CAPLYTA, BRIXADI, VIVITROL, SUBLOCADE, NEUROSTAR TMS THERAPY SYSTEM, INGREZZA.
Industry payments across PA — which companies pay providers there.
